Dr Stephan Neuhaus
Partner
Duesseldorf
Dr Stephan Neuhaus
Partner
Duesseldorf
Contact details
Stephan is a patent litigator with more than a decade of experience in protecting his international and national client’s market position with a specific focus on the life sciences and chemical industries as well as the telecommunications and the engineering sector. Stephan coordinates parallel patent infringement and revocation proceedings in the major European countries, helping clients devise effective cross-border litigation strategies.
He conducts main action infringement proceedings, preliminary injunction proceedings and inspection proceedings at the German district and appellate courts as well as nullity actions at the German Federal Patent Court and the Federal Supreme Court. His strategic advice covers questions regarding the new Unified Patent Court and the European Patent with unitary effect.
Stephan is recognized as “a known quantity in the life sciences and telecoms spheres” (IAM Patent 1000, 2020) and as “life sciences sage who has proved his mettle in a plethora of its actions before the Federal Patent Court and the Federal Court of Justice” (IAM Patent 1000, 2018). His “adroitness in presenting strong life sciences arguments is much-appreciated by those who rely on him in court” (IAM Patent 1000, 2019). Clients also praise his “unbeatable rhetoric skills in court and great personality” (IP Stars 2017). They appreciate his “written submissions of top quality” and his “excellent all-round knowledge of law and business” (IP Stars, 2016).
Expertise
Practices
Intellectual Property Disputes
Litigation, Arbitration and Investigations
Sectors
Qualifications
Professional
Academic
Dr iur, Universität Bayreuth, Germany, 2010
Second German Law Degree, Higher Regional Court of Frankfurt a.M., Germany, 2011
First German Law Degree, Universität Bayreuth, Germany 2005
Related articles
Publications: 25 August 2023
On 24 August 2023 the UPC Central Division (Section Munich) issued its first ever decision on a preliminary objection in the case No. UPC_CFI_1/2023.
Publications: 22 August 2023
UPC Insights: New technical judges appointed from courts and IPOs
Experience highlights
Equivalent patent infringement: Advising a global pharmaceutical and healthcare company on numerous preliminary injunction, main action, and its proceedings against numerous generics regarding the company’s chemotherapy drug Alimta® (pemetrexed) including winning precedent setting appeal regarding equivalent patent infringement in Germany (previous firm experience)
Advising major Swiss pharmaceutical company on pan-European strategy and coordinating pan-European enforcement of patents against market entry of biosimilar products (previous firm experience)
Advising major US biotechnology innovator on strategy enforcing patents protecting biological drugs against biosimilar competition including coordinating cross-border proceedings and conducting preliminary injunction proceedings in Germany (previous firm experience)
Conducting inspection/evidence gathering proceedings, specifically for inspection of specific sections of the pharmaceutical dossier or for inspection of an antibody manufacturing process at defendants premises (previous firm experience)
Expertise
Practices
Intellectual Property Disputes
Litigation, Arbitration and Investigations
Sectors
Qualifications
Professional
Academic
Dr iur, Universität Bayreuth, Germany, 2010
Second German Law Degree, Higher Regional Court of Frankfurt a.M., Germany, 2011
First German Law Degree, Universität Bayreuth, Germany 2005
Published work
- Stephan Neuhaus, Anm. zu BGH - Cerdioxid, GRUR 2021, 1043, 1048
Recognition
Neuhaus is a known quantity in the life sciences and telecoms spheres, and regularly conducts parallel litigations across key European jurisdictions.
IAM Patent 1000, 2020
Stephan Neuhaus [is] a quadrilingual litigator whose adroitness in presenting strong life sciences arguments is much-appreciated by those who rely on him in court.
IAM Patent 1000, 2019
Stephan Neuhaus is a life sciences sage who has proved his mettle in a plethora of nullity actions before the Federal Patent Court and the Federal Court of Justice.
IAM Patent 1000, 2018
Awards & accolades
"Rising Star Intellectual Property"
LMG Europe Rising Stars Award 2019
